Ligand validation:6M82

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 6M82 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6M82_SAH_A_301	94%	29%	0.079	0.979	1.06	1.74	2	4	0	0	100%	1
3PX2_SAH_A_263	99%	27%	0.049	0.989	1.1	1.84	1	7	0	0	100%	1
3PX3_SAH_D_264	99%	21%	0.06	0.989	1.18	2.1	1	8	0	0	100%	1
4OQD_SAH_A_300	97%	18%	0.065	0.978	1.24	2.23	3	8	0	0	100%	1
6M83_SAH_A_301	97%	31%	0.065	0.978	1.1	1.63	2	3	0	0	100%	1
3PFH_SAH_D_264	97%	29%	0.068	0.98	1.19	1.63	3	6	0	0	100%	1
2OB2_SAH_A_1801	100%	22%	0.023	0.994	1.25	1.94	3	4	0	0	100%	1
2BB3_SAH_B_203	100%	9%	0.027	0.993	2.32	2.18	9	6	4	0	100%	1
3LGA_SAH_B_301	100%	22%	0.027	0.994	1.32	1.89	2	3	0	0	100%	1
4QPP_SAH_A_1000	100%	37%	0.025	0.995	0.99	1.46	2	4	0	0	100%	1
8QXQ_SAH_A_401	100%	51%	0.028	0.994	0.84	1.04	1	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.